Approvals/NMPA/Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（III）

Approved

化学药品

Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（III）

上海汇伦医药股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8pt1ZDcssgr
Approval Number: 国药准字H20269000
Generic Name: 恩格列净二甲双胍缓释片(Ⅲ)
Generic Name En: Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（III）
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含恩格列净12.5mg与盐酸二甲双胍1000mg
Reg Date: 2026-01-04
Company Name: 上海汇伦医药股份有限公司
Company Address: 上海市闵行区元江路525号5幢10层
Production Company Name: 上海汇伦江苏药业有限公司
Production Company Address: 泰州市健康大道801号28幢
Company Detail Path: /organization/shang-hai-hui-lun-yi-yao-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/shang-hai-hui-lun-jiang-su-yao-ye-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 4, 2026

Approval ID

8pt1ZDcssgr

Type

化学药品